Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Blood Reviews|January 1, 2021
Anti-body building: The exercise of advancing immune based myeloma therapiesJoshua Richter, Santiago ThibaudSeminars in Oncology|May 25, 2020
Therapeutic potential of isatuximab in the treatment of multiple myeloma: Evidence to dateJoshua Richter, Larysa Sanchez, Santiago ThibaudInternational Journal of Laboratory Hematology|August 14, 2020
Ferritin levels in patients with COVID-19: A poor predictor of mortality and hemophagocytic lymphohistiocytosisJonathan Feld, Douglas Tremblay, Santiago Thibaud, et al.Blood Reviews|April 20, 2026
Environmental exposures and multiple myeloma risk: A contemporary review of epidemiologic associations and mechanistic plausibilityMaria Victoria Del Rosal, Mike Z He, Sundar Jagannath, et al.Seminars in Hematology|December 25, 2024
FaMMily Affairs: Dissecting inherited contributions to multiple myeloma riskSaoirse Bodnar, Tehilla Brander, Julie Gold, et al.Hepatology International|August 3, 2019
Association between neutrophil-lymphocyte ratio, socioeconomic status, and ethnic minority with treatment outcome in hepatocellular carcinomaYifei Zhang, N Patrik Brodin, Nitin Ohri, et al.Haematologica|April 23, 2026
Effect of intravenous immunoglobulin on infections in multiple myeloma patients receiving daratumumabGuido Lancman, Dahniel Sastow, Minira Aslanova, et al.Bone Marrow Transplantation|May 3, 2025
Extramedullary disease but not paraskeletal disease portends inferior outcomes after CAR T cell therapy in multiple myelomaDarren Pan, Tarek H Mouhieddine, Tianxiang Sheng, et al.Bone Marrow Transplantation|October 19, 2022
Bridging advanced myeloma patients to subsequent treatments and clinical trials with classical chemotherapy and stem cell supportTarek H Mouhieddine, Erin Moshier, Santiago Thibaud, et al.Blood Cancer Discovery|September 28, 2023
IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific AntibodiesGuido Lancman, Kian Parsa, Krzysztof Kotlarz, et al.Pageof 3